Firm News: Drugs & Devices: Page 9

W&L Investigating Injuries Caused by Recalled Beacon Tip Angiographic Catheters from Cook Medical

Weitz & Luxenberg, P.C., today launched an investigation into injuries sustained by patients when catheters used during cardiac angiogram procedures to inject contrast dye into blood vessels malfunctioned by either splitting or separating. The probe centers around one particular brand of angiographic catheters made by Cook Medical of Bloomington, Indiana. The recall, classified as a Class…

W&L Investigating EMPERION Modular Hip System Cases

W&L is investigating cases of fracture associated with the EMPERION Modular Hip System manufactured by Smith & Nephew Inc. of Memphis, Tennessee. The investigation was prompted by recent medical literature, fracture and revision reports discovered in the U.S. Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database, and an analysis by…

HarrisMartin’s MDL Conference Features W&L Attorney As Invited Faculty

W&L attorney David L. Rosenband has been invited as a faculty member for the upcoming HarrisMartin MDL Conference: Zofran, Bard IVC and Zimmer Persona Knee Litigation. Rosenband serves as an associate attorney on our Defective Drugs and Devices team. An experienced litigator, he has been involved in a number of significant medical device and pharmaceutical…

Taking SGLT2 Inhibitors May Result in Diabetic Ketoacidosis

W&L is now accepting cases of diabetic ketoacidosis that resulted in the hospitalization or death of people who ingested any of the sodium glucose cotransporter-2 (SGLT2) inhibitors. SGLT2 inhibitors are a class of medications indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This drug…

W&L Exploring Reports of Zimmer ProxiLock Hip Femur Fracture Rates

Prompted by a recent study, Weitz & Luxenberg, P.C. is investigating the ProxiLock Hip Prosthesis stem manufactured by Zimmer Inc. The implant was originally manufactured by Implex Corp., and was given 510(k) approval by at least October, 2002. Zimmer Inc. announced an agreement to acquire Implex in November, 2003. The study, “Increased Risk of Periprosthetic…